Global Health HICP by Country

In 2024, Hungary leads the Global Health HICP at 11.8%, followed by Slovakia (10.2%) and Estonia (9.9%). Lithuania, Latvia, and Slovenia each hover around 9-10%. Central European countries, like the Czech Republic at 8.9%, remain high, contrasting with Western Europe and Nordic countries such as Germany (2.9%) and Denmark (3.5%). Ireland and Switzerland show negative inflation, a rarity with -0.2% and -0.3%, respectively. Finland has the lowest at -1.5%. Notable outliers include the United States at 2.7% and Austria at 5.2%.

Future trends to watch include potential economic shifts from geopolitical tensions, healthcare reforms, and increasing demand for health services which may drive higher inflation rates in this sector globally. Additionally, developments in pharmaceutical innovations and pricing strategies could significantly impact the HICP in coming years.